Combination Treatment of Ligustrazine Piperazine Derivate DLJ14 and Adriamycin Inhibits Progression of Resistant Breast Cancer Through Inhibition of the EGFR/PI3K/Akt Survival Pathway and Induction of Apoptosis

Drug discoveries & therapeutics - Japan
doi 10.5582/ddt.8.33
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Related search

miR‑320/ELF3 Axis Inhibits the Progression of Breast Cancer via the PI3K/AKT Pathway

Oncology Letters
Cancer ResearchOncology
2020English

Rapamycin Inhibits Proliferation and Apoptosis of Retinoblastoma Cells Through PI3K/AKT Signaling Pathway

Oncology Letters
Cancer ResearchOncology
2020English

Frequent Mutational Activation of the PI3K-AKT Pathway in Trastuzumab-Resistant Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2012English

Inhibition of Cell Growth and Induction of Apoptosis byAntrodia Camphoratain HER-2/neu-Overexpressing Breast Cancer Cells Through the Induction of ROS, Depletion of HER-2/neu, and Disruption of the PI3K/Akt Signaling Pathway

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2012English

Vertical Inhibition of the PI3K/Akt/mTOR Pathway Is Synergistic in Breast Cancer

Oncogenesis
Cancer ResearchMolecular Biology
2017English

Inhibition of Esophageal Cancer Growth Through the Suppression of PI3K/AKT/mTOR Signaling Pathway

OncoTargets and Therapy
OncologyPharmacology
2019English

Ligustrazine Inhibits Platelet Activation via Suppression of the Akt Pathway

International Journal of Molecular Medicine
MedicineGenetics
2018English

BMP9 Inhibits the Growth of Breast Cancer Cells by Downregulation of the PI3K/Akt Signaling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2018English

miR-19b Serves as a Prognostic Biomarker of Breast Cancer and Promotes Tumor Progression Through PI3K/AKT Signaling Pathway

OncoTargets and Therapy
OncologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy